Home > News > Is There Any Evidence for Surgical Intervention in Childhood Epiphora?
Anterior Segment, Paediatric Ophthalmology
Read Time: 6 mins

Is There Any Evidence for Surgical Intervention in Childhood Epiphora?

Published Online: March 2nd 2011 European Ophthalmic Review, 2009,3(1):39-41 DOI: http://doi.org/10.17925/EOR.2009.03.01.39
Authors: Caroline J MacEwen, Whye Onn Ho
Quick Links:
Abstract
Article
Article Information
Abstract:
Overview

Epiphora in infants is common, and there is no evidence that surgical interventions during the first year of life have any advantage over the natural history of spontaneous resolution in terms of cure rate. Probing at between 12 and 15 months of age has been shown to provide an earlier improvement than simple observation, but by two years of age there is no difference between those probed and those not probed. There are no good studies comparing the value of endoscopic probing versus the use of intubation and balloon dacryocystplasty either as primary or secondary procedures. External and endonasal dacrycystorhinostomies (DCRs) are both useful procedures, but they have not been directly compared in terms of the benefits of one versus the other.

Keywords

Congenital naso-lacrimal duct obstruction, spontaneous resolution, probing, intubation, paediatric dacrycystorhinostomy (DCR)

Article:

The most common outcome of infantile epiphora is spontaneous resolution,1–10 although surgical intervention in the form of syringing and probing is advocated for cases that fail to settle.11–18 More complex surgical procedures such as intubation, balloon dilatation and dacryocystorhinostomy (DCR) may be indicated when the epiphora persists. There is considerable controversy surrounding the management – both conservative and surgical – of childhood epiphora, mainly due to a literature based on the lower levels of evidence such as case reports, expert opinion and non-controlled, mainly retrospective, series. Higher levels of evidence such as systematic reviews, meta-analyses and randomised controlled studies (RCTs) are lacking in this clinical area. The evidence to support some of the surgical options will be explored in this article.

Congenital naso-lacrimal duct obstruction (CNLDO) is caused by a membranous obstruction at the distal end of the NLD.19,20 Obstruction at other sites is much rarer but becomes clinically more relevant in older children as those with CNLDO spontaneously resolve. These obstructions may be complex and have a different natural history andoutcome from CNLDO. However, it is not possible to identify the more complicated causes of epiphora on clinical grounds, although it is this group that may benefit most from surgical intervention.

Syringing and Probing
There is extensive literature on the use of probing in the management of childhood epiphora, and the rates of probing success are between 86 and 96% in mainly retrospective case series in the first year of life.11,14–18 These are impressive figures for any surgical procedure; however, these results must be viewed in light of a condition that has been shown in both retrospective series and prospective cohort observational studies to have a spontaneous resolution rate of between 89 and 96% by one year of age.1,3–9 There is no study in children during the first year of life that evaluates the success rate of probing using a control group.

Does probing have the advantage of effecting a more rapid cure than observation? Uncontrolled studies of probing up to six months of age indicate a success rate of 79–98%2,11,15 compared with a natural resolution rate of 76–100% during the same time-frame.1,3,4,6,7,10 This indicates that there is no convincing evidence to demonstrate that probing offers any advantage in terms of the speed of reduction of symptoms and takes place at the cost of probing considerable numbers of children who would spontaneously remit. A prospective observational study found that 90% of those with epiphora at three months of age, 75% of those at six months of age and 36% of those at nine months of age resolved by one year of age.1

Does early probing have a higher success rate than when it is performed later? There is some evidence to support this,15,21 although other work has identified either no difference in success rate of probing at different ages8,11–13,22,23 or that the higher failure rate in older children is unrelated to age, but is due to a process of natural selection.9,11,18,24–27 As children grow older, more complex and severe obstructions become increasingly common; this, in turn, reduces the success rate of probing in older children. Studies that have critically evaluated the causes of ‘probing failure’ and those that have endoscopically viewed the distal end of the NLD during probing have demonstrated that the success of probing is determined more by the nature of the obstruction than by the age of the patient.25–27

Resolution continues after one year of age3,8,28,29 and by 24 months of age 60–79% of symptomatic one-year-olds have been shown to have spontaneously improved.8,29 There is only one prospective, controlled study into the success rate of probing during the second year of life; this identified that probing and syringing between 12 and 14 months of age was more successful than the spontaneous resolution rate in a control group at 15 months, but by two years of age there was no statistical difference in the outcome between those probed and those not probed due to continued spontaneous resolution in the control group.29 This study indicates that observation is as effective as probing in children up to two years of age, but that probing provides a more rapid result if performed at, or just after, 12 months of age. It also indicates that early and late probing are equally effective and that there is no disadvantage in terms of eventual outcome by delaying probing.

Endoscopic Probing
Endoscopic probing was introduced because standard probing is a blind procedure that makes it liable to complication, particularly in systems that are already anatomically abnormal. This involves direct visualisation of the distal end of the NLD and provides information in terms of the nature of the obstruction (stenosis or atresia). It also either observes the passage of the probe directly into the inferior meatus or identifies the development of a false passage and provides an opportunity to rectify this.30,31 Endonasal studies have identified that the result was converted from failure to success due to an intranasal manipulation when the result was between 11 and 36%.31–33 Is this justified? There have been no prospective randomised studies comparing blind versus endonasal probing as either a primary or a secondary procedure; these are required to evaluate this development properly, especially in older children who are more likely to benefit.

What to Do If Probing Fails
Studies into the management of persistent epiphora following probing are generally limited due to a lack of consensus regarding what a ‘failed probing’ means in anatomical terms. Lack of success is usually due to physiological (functional) epiphora, failure to create a patent passage between the NLD and the inferior meatus or complex abnormalities of the upper outflow system. Each of these requires a different management plan varying from observation to re-probing – preferably using endoscopy to aid diagnosis – to a variety of procedures to rectify complicated abnormalities. These include intubation of the lacrimal system with silastic or silicone tubes, balloon dilation and DCR. Evaluation of the role for these other techniques in ‘probing failure’ is problematic due to the poor definition of this entity.

Intubation and Balloon Dacryocystoplasty
Intubation of the lacrimal system is usually recommended for cases where conservative treatment and probing have failed, with a quoted success rate of between 80 and 97%.34–37 A retrospective analysis of two groups of children – one that underwent probing and the other that was intubated for continued epiphora after one probing – found no difference in the outcomes of each group.38 Intubation has also been promoted as a primary procedure, mainly in older children with persistent symptoms.39–43 The results of these retrospective studies indicate that more than 90% are cured by this intervention; however, these results do not differ from those of late probings.12,13,22,27

An alternative to intubation in cases of failed probings is balloon dacryocystoplasty (DCP).44–46 This process involves passing a balloon catheter into the NLD to dilate a stenosed passage and is successful in between 74 and 94% of cases in retrospective studies.44–46 This is an expensive procedure,47 but despite this, and the lack of any concrete evidence of its benefits compared with probing,12,13,22,27 it has been advocated as a primary procedure instead of probing.48,49 One prospective non-controlled study identified a success rate of 79%,48 with this result being unaffected by either the age of the child or the extent of the NLD obstruction. A retrospective review comparing balloon DCP with probing as a primary procedure for CNLDO found that both were equally successful.50

A recent prospective randomised trial comparing transnasal endoscopic assisted balloon dilatation with bicanalicular silicone intubation for the primary surgical treatment of congenital nasolacrimal duct obstruction in children over three years of age identified that balloon dilatation was more effective (90%) than intubation (62.5%).51 Although statistically significant, this study has small groups of 20–24 patients in each arm of treatment.

Dacryocystorhinostomy
External DCR achieves a good success rate in large case series ranging from 83 to 96% in cases of CNLDO with chronic dacryocystitis when medical therapy, probing and silicone intubation have been unsuccessful.52–54 The complication rate is low (3%) and the procedure is well-tolerated in children.53 In expert hands, DCR is a successful treatment for appropriately selected paediatric cases with complex lacrimal outflow obstruction in the absence of cannalicular disease.

With the advent of endoscopic techniques and small-diameter endoscopes with wide-angled fields of view, intranasal visualisation has improved and hence allowed DCR to be performed endoscopically. Endoscopic DCR takes much less time and therefore can be carried out safely as an outpatient procedure. The overall success rate of endoscopic DCR ranges from 82 to 88%.55–57

Summary
Currently, there is no evidence to determine the effectiveness of probing in children less than one year of age compared with simple observation. An adequately powered RCT of probing versus observation poses a difficult challenge and is probably not feasible. With such high rates of success for probing and natural resolution, a study of huge proportions would need to be performed in order to prove or refute the benefits of probing. There is better evidence to support probing at 12–15 months of age, but the effect is not sustained and there is no benefit by the time children reach two years of age.29 It is impossible to draw reliable conclusions from the evidence available regarding intubation and balloon DCP. Welldesigned RCTs are needed to establish the role of these options. More research is required to clarify what constitutes a ‘failed probing’ and the role of surgical options in the management of this condition.

Article Information:
Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Caroline J MacEwen, Department of Ophthalmology, Ninewells Hospital, Dundee, DD1 9SY, UK. E: c.j.macewen@dundee.ac.uk

Received

2009-03-17T00:00:00

References

  1. MacEwen CJ, Young JDH, Epiphora during the first year of life, Eye, 1991;5:596–600.
  2. Ffookes OO, Dacryocystitis in infancy, Br J Ophthalmol, 1962;46:422–34.
  3. Price HW, Dacryostenosis, J Pediatr, 1947;30:302–5.
  4. Peterson RA, Robb RM, The natural course of congenital obstruction of the nasolacrimal duct, J Pediatr Ophthalmol Strabismus, 1978;15:246–50.
  5. Paul TO, Medical management of congenital nasolacrimal duct obstruction, J Pediatr Ophthalmol Strabismus, 1985;22: 68–70.
  6. Korchmaros I, Szalay E, Fordor M, Jablonszky E, Spontaneous opening rate of congenitally blocked nasolacrimal ducts. In: Recent Advances in the Lacrimal System, Yamaguchi M (ed.), Tokyo: Asahi, 1981;31–5.
  7. Noda S, Hayasaka S, Setogawa T, Congenital nasolacrimal duct obstruction in Japanese infants; its incidence and treatment with massage, J Pediatr Ophthalmol Strabismus, 1991;28:20–22.
  8. Nucci P, Capoferri C, Alafarano R, Brancato R, Conservative management of congenital nasolacrimal duct obstruction, J Pediatr Ophthalmol Strabismus, 1989;26: 39–43
  9. Nelson IB, Calhoun JH, Menduke H, Medical management of congenital nasolacrimal duct obstruction, Ophthalmology, 1985;92:1187–90.
  10. Guerry D, Kendig EL, Congenital impatency of the nasolacrimal duct, Arch Ophthalmol, 1948;39:193–204.
  11. Robb R, Probing and irrigation for congenital nasolacrimal duct obstruction, Arch Ophthalmol, 1986;104:378–9.
  12. Maheshwari R, Results of probing for congenital nasolacrimal duct obstruction in children older than 13 months of age, Indian J Ophthalmol, 2005;53(1):49–51.
  13. Honavar SG, Prakash VE, Rao GN, Outcome of probing for congenital nasolacrimal duct obstruction in older children, Am J Ophthalmol, 2000;130(1):42–8.
  14. Baker JD, Treatment of congenital naso-lacrimal duct obstruction, J Pediatr Ophthalmol Strabismus, 1985;22:34–5.
  15. Katowitz JA, Welsh MG, Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction, Ophthalmology, 1987;94:698–705.
  16. Paul TO, Shepherd R, Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention, J Pediatr Ophthalmol Strabismus, 1994;31:362–7.
  17. Koke MP, Treatment of occluded naso-lacrimal ducts in infants, Arch Ophthalmol, 1950;43:750–54.
  18. Kashkouli MB, Kassaee A, Tabatabaee Z, Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success, J Pediatr Ophthalmol Strabismus, 2002;6:360–63.
  19. Cassady JV, Developmental anatomy of the nasolacrimal duct, Arch Ophthalmol, 1952;47:141–58.
  20. Cassady JV, Dacryocystitis in infancy, Am J Ophthamol, 1948; 31:773–80.
  21. Mannor GE, Rose GE, Frimpong-Ansah K, Ezra E, Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction, Am J Ophthalmol, 1999;127:616–17.
  22. Zwaan J, Treatment for congenital naso-lacrimal duct obstruction before and after the age of 1 year, Ophthalmic Surg Lasers, 1997;28(11):932–6.
  23. Calhoun JH, Problems of the lacrimal system in children, Ped Ophthalmol, 1987;34:1457–65.
  24. El-Mansoury J, Calhoun JH, Nelson LB, Harley ROD, Results if late probing for congenital nasolacrimal obstruction, Ophthalmology, 1986;93:1052–4.
  25. Wallace EJ, Cox A, White P, MacEwen CJ, Endoscopic control of probing in children, Eye, 2006;20:998–1003.
  26. Choi WC, Kim KS, Park TK, Chung CS, Intranasal endoscopic diagnosis and treatment in congenital nasolacrimal duct obstruction, Ophthalmic Surg Lasers, 2002;33(4):288–92.
  27. Zilelioglu G, Hosal BM, The results of late probing in congenital nasolacrimal duct obstruction, Orbit, 2007;26:1–3.
  28. Schellini SA, Ferreira Ret al., Spontaneous resolution in congenital nasolacrimal duct obstruction after 12 months, Semin Ophthalmol, 2007;22:71–4.
  29. . Young JDH, MacEwen CJ, Ogsten SA, Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management, Eye, 1996;10:485–91.
  30. Ram B, Barras CW, White PS, et al., The technique of nasendoscopy in the evaluation of naso-lacrimal duct obstruction in children, Rhinology, 2000;38:83–6.
  31. Ingels K, Kestelyn P, Meire F, et al., The endoscopic approach for congenital nasolacrimal duct obstruction, Clin Otolaryngol Allied Sci, 1997;22(2):96–9.
  32. MacEwen CJ, Barras C, White P, et al., Value of nasal endoscopy and probing in the diagnosis and management of children with congenital epiphora, Br J Ophthalmol, 2001;85:314–18.
  33. Sener EC, Onerci M, Reappraisal of probing of the congenital obstruction of the nasolacrimal system: Is nasal endoscopy essential?, Int J Pediatr Otorhinolaryngol, 2001;58(1):65–8.
  34. Lim CS, Martin F, Beckenham T, Cumming RG, Nasolacrimal duct obstruction in children: Outcome of intubation, J AAPOS, 2004;8(5):466–72.
  35. Aggrawal RK, Misson GP, Donaldson I, Willshaw HE, The role of naso-lacrimal intubation in the management of childhood epiphora, Eye, 1993;7:760–62.
  36. Leone CR Jr, Van Gemert JV, The success rate of silicone intubation in congenital lacrimal obstruction, Ophthalmic Surg, 1990;21(2):90–92.
  37. Dortzbach RK, France TD, Kushner BJ, Gonnering RS,. Silicone intubation for obstruction of the nasolacrimal duct in children, Am J Ophthalmol, 1982;94(5):585–90
  38. Chen PL, Hsiao CH, Balloon dacryocystoplasty as the primary treatment in older children with congenital nasolacrimal duct obstruction, J AAPOS, 2005;9(6):546–9.
  39. al-Hussain H, Nasr AM, Silastic intubation in congenital nasolacrimal duct obstruction: a study of 129 eyes, Ophthal Plast Reconstr Surg, 1993;9(1):32–7.
  40. Kaufman LM, Guay-Bhatia LA, Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction, Ophthalmology, 1998; 105(2): 336–41.
  41. Ratliff CD, Meyer DR, Silicone intubation without intranasal fixation for treatment of congenital nasolacrimal duct obstruction, Am J Ophthalmol, 1994;118(6):781–5.
  42. Pe MR, Langford JD, Linberg JV, Schwartz TL, Sondhi N, Ritleng intubation system for treatment of congenital nasolacrimal duct obstruction, Arch Ophthalmol, 1998; 116(3):387–91.
  43. Gardiner JA, Forte V, Pashby RC, Levin AV, The role of nasal endoscopy in repeat pediatric naso-lacrimal duct probings, JAAPOS, 2001;5:148–52.
  44. Becker BB, Berry FD, Balloon catheter dilatation in pediatric patients, Ophthalmic Surg, 1991;22:750–52.
  45. Yuksel D, Ceylan K, Erden O, et al., Balloon dilation for treatment of congenital nasolacrimal duct obstruction, Eur J Ophthalmol, 2005;15(2):179–85.
  46. Tao S, Meyer DR, Simon JW, Zobal-Ratner J, Success of balloon catheter dilation as a primary or secondary procedure for congenital nasolacrimal duct obstruction, Ophthalmology, 2002;109(11):2108–11.
  47. Kushner BJ, Balloon catheter dilatation for congenital naso-lacrimal duct obstruction, Am J Ophthalmol, 1996; 122:598–9.
  48. Chen PL, Hsiao CH, Balloon dacryoplasty as the primary treatment in older children with congenital nasolacrimal duct obstruction, J AAPPOS, 2005;9:546–9.
  49. Kraft SP, Crawford JS, Silicone tube intubation in disorders of the lacrimal system in children, Am J Ophthalmol, 1982; 94(3):290–99.
  50. Gunton KB, Chung CW, Schnall BM, et al., Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction, J AAPOS, 2001;5(3):139–42.
  51. Ceylan K, Yuksel D, Duman S, Samim E, Comparison of two endoscopically assisted procedures in primary surgical treatment of congenital nasolacrimal duct obstruction in children older than 3 years: balloon dilatation and bicanalicular silicone tube intubation, Int J Pediatr Otorhinolaryngol, 2007;71(1):11–17.
  52. Hakin KN, Sullivan TJ, Sharma A, Whelam RAN, Paediatric dacryocystorhinostomy, Aust NZ J Ophthalmol, 1994;22: 231–5.
  53. Barnes EA, Abou-Rayyah Y, Rose GE, Pediatric dacryocystorhinostomy for nasolacrimal duct obstruction, Ophthalmology, 2001;108(9):1562–4.
  54. Nowinski TS, Flanagan JC, Mauriello J, Pediatric dacryocystorhinostomy, Arch Ophthalmol, 1985; 103(8):1226–8.
  55. Vanderveen DK, Jones DT, Tan H, Petersen RA, Endoscopic dacryocystorhinostomy in children, J AAPOS, 2001;5:143–7.
  56. Jones DT, Fajardo NF, Petersen RA, VanderVeen DK, Pediatric endoscopic dacryocystorhinostomy failures: who and why?, Laryngoscope, 2007;117(2):323–7.
  57. Kominek P, Cervenka S, Pediatric endonasal dacryocystorhinostomy: a report of 34 cases, Laryngoscope, 2005;115(10):1800–1803.

Further Resources

Share this Article
Related Content In Paediatric Ophthalmology
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72